Zhang Y X, Stewart S J, Caldwell H D
Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 59840.
Infect Immun. 1989 Feb;57(2):636-8. doi: 10.1128/iai.57.2.636-638.1989.
Monoclonal antibodies exhibiting Chlamydia trachomatis serovar specificity (serovar A, B-Ba, or C) and serogroup specificity (B, intermediate, or C serogroup) were produced and characterized. These antibodies reacted with the major outer membrane protein, recognized epitopes located at the chlamydial cell surface, and passively neutralized chlamydial toxicity for mice. The antibodies should be useful reagents for defining the molecular structure of these protective epitopes, a necessary step toward the development of a subunit or recombinant C. trachomatis vaccine.
制备并鉴定了具有沙眼衣原体血清型特异性(血清型A、B - Ba或C)和血清群特异性(B、中间型或C血清群)的单克隆抗体。这些抗体与主要外膜蛋白发生反应,识别位于衣原体细胞表面的表位,并被动中和衣原体对小鼠的毒性。这些抗体应是用于确定这些保护性表位分子结构的有用试剂,这是开发亚单位或重组沙眼衣原体疫苗的必要步骤。